alexa Adeno-Associated Virus-Based Transgene Delivery for Treating of Progressive Vascular Diseases

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Adeno-Associated Virus-Based Transgene Delivery for Treating of Progressive Vascular Diseases

There has been much progress in the clinical treatment of Progressive Vascular Diseases (PVD) since the introduction of statins, calcium channel blockers, and other relevant drugs. Yet long term PVD still plagues much of our aged population. The use of gene therapy, delivering therapeutic transgenes, should provide both long-term and safe treatment, as well as more physiologically relevant treatments. Adeno-associated Virus (AAV) can provide long term and safe gene delivery, very appropriate for long term PVD. In regards to therapeutic transgenes for the treatment of PVD, there is the choice of several gene categories, all of which may provide a significant level of efficacy yet have different metabolic modes of action. As examples there are anti-inflammatory cytokine genes, blood lipoproteinmetabolism genes, and anti-oxidant genes.

Citation: Hermonat PL (2014) Adeno-Associated Virus-Based Transgene Delivery for Treating of Progressive Vascular Diseases. Clon Transgen 3:e111. doi: 10.4172/2168-9849.1000e111

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords